巴克莱：中国行_加速生物制药创新及业务发展机遇

Cross Asset Research 10 June 2025 European Pharmaceuticals & Life Sciences On the Road in China: Accelerating Biopharma Innovation and Business Development Opportunities China's biopharma sector is regaining momentum, driven by rising innovation & renewed deal activity with MNC partners. We report key takeaways from our field trip, highlighting both near-term BD opportunities and long-term strategic relevance of the region; we see OW-rated AZN and SAN as LT winners. Listen Our recent two-week visit to China ...